1. Home
  2. ABCL vs DCO Comparison

ABCL vs DCO Comparison

Compare ABCL & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • DCO
  • Stock Information
  • Founded
  • ABCL 2012
  • DCO 1849
  • Country
  • ABCL Canada
  • DCO United States
  • Employees
  • ABCL N/A
  • DCO N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • DCO Military/Government/Technical
  • Sector
  • ABCL Health Care
  • DCO Industrials
  • Exchange
  • ABCL Nasdaq
  • DCO Nasdaq
  • Market Cap
  • ABCL 1.1B
  • DCO 1.4B
  • IPO Year
  • ABCL 2020
  • DCO N/A
  • Fundamental
  • Price
  • ABCL $5.62
  • DCO $93.42
  • Analyst Decision
  • ABCL Strong Buy
  • DCO Strong Buy
  • Analyst Count
  • ABCL 5
  • DCO 4
  • Target Price
  • ABCL $8.00
  • DCO $119.75
  • AVG Volume (30 Days)
  • ABCL 5.6M
  • DCO 159.3K
  • Earning Date
  • ABCL 11-06-2025
  • DCO 11-06-2025
  • Dividend Yield
  • ABCL N/A
  • DCO N/A
  • EPS Growth
  • ABCL N/A
  • DCO 73.00
  • EPS
  • ABCL N/A
  • DCO 2.65
  • Revenue
  • ABCL $32,875,999.00
  • DCO $795,078,000.00
  • Revenue This Year
  • ABCL $16.99
  • DCO $6.20
  • Revenue Next Year
  • ABCL $62.91
  • DCO $8.02
  • P/E Ratio
  • ABCL N/A
  • DCO $35.24
  • Revenue Growth
  • ABCL N/A
  • DCO 2.42
  • 52 Week Low
  • ABCL $1.89
  • DCO $51.76
  • 52 Week High
  • ABCL $6.52
  • DCO $101.47
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 52.96
  • DCO 47.88
  • Support Level
  • ABCL $5.33
  • DCO $88.20
  • Resistance Level
  • ABCL $5.97
  • DCO $101.47
  • Average True Range (ATR)
  • ABCL 0.35
  • DCO 4.06
  • MACD
  • ABCL -0.06
  • DCO -0.28
  • Stochastic Oscillator
  • ABCL 32.28
  • DCO 39.34

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: